about
Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitisPharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studiesAllergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent.Investigational new drugs for allergic rhinitis.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs for allergic conjunctivitis.
@en
type
label
Emerging drugs for allergic conjunctivitis.
@en
prefLabel
Emerging drugs for allergic conjunctivitis.
@en
P2093
P2860
P50
P1476
Emerging drugs for allergic conjunctivitis.
@en
P2093
Gianenrico Senna
Marcello Montagni
Marco Caminati
P2860
P304
P356
10.1517/14728214.2014.902443
P407
P577
2014-03-25T00:00:00Z